Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Durex-Maker Reckitt Avoids $20 Billion Headache

Wall Street Journal - 22 Mar 2018 15:37
Turning down Pfizer's $20 billion consumer-health business shows discipline, but leaves U.K. giant Reckitt Benckiser with plenty of work.
Full Article at Wall Street Journal

More Market News
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard